Pharmaceutical Grade Lorazepam API from Japan
High-purity lorazepam active pharmaceutical ingredient certified for human medicinal use, meeting cGMP standards. Specifically classified under HTS 2933.91.0010 as the named compound lorazepam (INN). Imported by generic drug manufacturers for tablet and capsule production.
Duty Rate — Japan → United States
27.5%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Submit FDA Drug Master File (DMF) reference and supplier qualification documents with entry
• Include batch-specific Certificates of Analysis showing >99% purity and absence of related substances
• Pre-clear with CBP via ACE system due to controlled substance status; avoid delays from missing DEA Form 236